About this trial

This project aims to collaborate with multiple medical institutions to verify the accuracy, stability, and clinical application value of AI algorithms in echocardiographic quantitative measurement through multi-center clinical research. Specific objectives include:

1. Compare the automatic measurement results of AI with the manual measurement data from physicians of different levels, and analyze the measurement deviation and consistency of AI in key parameters such as intracardiac diameter, volume, and function. 2. Investigate whether AI-assisted measurement can significantly reduce echocardiogram analysis time and optimize clinical workflows. Through multi-center data validation, establish a standardized reference system for AI ultrasound measurement, promote the promotion and application of AI technology in medical institutions at all levels, and reduce diagnostic differences between different hospitals and physicians. 3. Exploring the application of AI in special cases: Assessing the measurement stability of AI algorithms in complex cases (such as cardiomyopathy, valvular disease, coronary heart disease, etc.), and optimizing AI models to meet broader clinical needs.

Eligibility criteria

Qualifiers

Age ≥18 - 80 years;

Normal heart

Coronary heart disease (with segmental thinning and abnormal movement)

Valve disease (valve stenosis or reflux)

Disqualifiers

Patients with congenital heart disease

Patients with poor image quality

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,600 Participants
are grouped into 3 trial groups

Locations

37
Huainan First People's Hospital HuainanAnhui, China
Union Hospital Affiliated to Fujian Medical University FuzhouFujian, China
Meizhou People's Hospital MeizhouGuangdong, China
Shantou Central Hospital ShantouGuangdong, China

Sponsors and collaborators

First Hospital of China Medical University

Lead sponsor